Summary
The in vivo effects of four Hr-antagonists, diphenhydramine, chlorpheniramine, mepyramine, and promethazine, on the metabolism of noradrenaline (NA), dopamine (DA), and 5-hydroxytryptamine (5-HT) were investigated in the whole mouse brain. Diphenhydramine and chlorpheniramine had no significant effect on levels of NA, 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), DA, and 5-HT, but they significantly decreased levels of 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA). In particular chlorpheniramine markedly decreased 5-HIAA levels at doses as low as 1 mg/kg, i. p. Mepyramine significantly decreased 5-HIAA levels but not those of other substances. High doses of promethazine significantly decreased NA levels but markedly increased those of MHPG, DOPAC, HVA, 5-HT, and 5-HIAA. The DA reduction induced by α-methyl-p-tyrosine (α-MT) was significantly inhibited by diphenhydramine, chlorpheniramine, and promethazine, but the α-MT-induced NA decrease was significantly enhanced by promethazine. The 5-HIAA accumulations induced by probenecid were significantly inhibited by chlorpheniramine and mepyramine. These results suggest: (1) Diphenhydramine and chlorpheniramine inhibit the turnover of both DA and 5-HT by blocking their neuronal uptake. (2) Promethazine and mepyramine inhibit DA and 5-HT turnover, respectively, as a result of the inhibition of the uptake mechanism. (3) Promethazine increases NA turnover by enhancing NA release. The discriminative effects of these drugs on the monoamine systems may be related to some differences in their CNS actions.
Similar content being viewed by others
References
Bluhm R, Zsigmond EK, Winnie AP (1982) Potentiation of opioid analgesia by H1 and H2 antagonists. Life Sci 31:1229–1232
Brown PA, Vernikos J (1980) Antihistamine effect on synaptosomal uptake of serotonin, norepinephrine and dopamine. Eur J Pharmacol 65:89–92
Coyle JT, Snyder SH (1969) Antiparkinsonian drugs: inhibition of depamine uptake in the corpus striatum as a possible mechanism of action. Science 166:899–901
Douglas WW (1985) Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics. MacMillan, New York, pp 605–638
Gerald MC, Richter NA (1976) Studies on the effects of histaminergic agents on seizure susceptibility in mice. Psychopharmacology 46:277–282
Isaac L, Goth A (1967) The mechanism of the potentiation of norepinephrine by antihistaminics. J Pharmacol Exp Ther 156:463–468
Itoh Y, Oishi R, Nishibori M, Saeki K, Furuno K, Fukuda T, Araki Y (1986) Lack of evidence for the involvement of catecholaminergic mechanisms in the behavioral anti-methamphetamine effect of l-histidine in the mouse. Pharmacol Biochem Behav 24.571–574
Kopera J, Armitage AK (1954) Comparison of some pharmacological properties of chlorpromazine, promethazine, and pethidine. Br J Pharmacol 9:392–401
Lidbrink P, Jonsson G, Fuxe K (1971) The effect of imipramine like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology 10:521–536
Nath C, Gulati A, Dhawan KN, Gupta GP, Bhargava KP (1982) Evidence for central histaminergic mechanism in foot shock aggression. Psychopharmacology 76:228–231
Oishi R, Mishima S, Kuriyama H (1983) Determination of norepinephrine and its metabolites released from rat vas deferens using high performance liquid chormatography with electrochemical detection. Life Sci 32:933–940
Onodera K (1987) Muricidal suppression by chlorpheniramine and changes in brain levels following dietary-induced thiamine deficiency in rats. Physiol Behav 41:71–78
Rogóz Z, Skuza G, Sowinska H (1981) The effect of the antihistaminic drugs on the central action of 5-hydroxytryptophan in mice. Pol J Pharmacol Pharm 33:459–465
Sun CLJ, Hui FW, Hanig JP (1985) Effect of H1 blockers alone and in combination with morphine to produce antinociception in mice. Neuropharmacology 24:1–4
Tuomisto J, Tuomisto L (1980) Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes. Med Biol 58:33–37
Young CS, Mason R, Hill SJ (1988) Inhibition by H1-antihistamines of the uptake of noradrenaline and 5-HT into rat brain synaptosomes. Biochem Pharmacol 37:976–978
Author information
Authors and Affiliations
Additional information
Send offprint requests to K. Saeki at the above address
Rights and permissions
About this article
Cite this article
Shishido, S., Oishi, R. & Saeki, K. In vivo effects of some histamine H1-receptor antagonists on monoamine metabolism in the mouse brain. Naunyn-Schmiedeberg's Arch Pharmacol 343, 185–189 (1991). https://doi.org/10.1007/BF00168608
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168608